A UK-based investment group has over £20 million under management. The group currently looks to invest in seed and early clinical stage companies in the life science space. The initial investment ranges from £50,000 to £300,000,but it will reserve capital for follow-on investments, and it can invest up to £1 million over a lifecycle. The group seeks to make 10-20 allocations over the next year. The group focuses on companies based in UK.
The group is currently looking for new opportunities in the Medical Devices, Diagnostics, Lab equipment and Healthcare IT sectors. The group will not invest in drug development companies. For medical devices, the group will consider all classes of devices but prefers devices with short regulatory pathways. The group is also interested companies that don’t require clinical trials. The group is generally opportunistic in terms of indication.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment